A case of scientific misconduct at Harvard.
US regulators are turning a blind eye to the risks of offshore clinical trials.
1 comment
There are some seriously progressive initiatives underway in the 112th Congress, and they deserve more attention than they're getting.
One of the agencies hardest hit by Congress’s 2011 appropriations bill is likely to be the world’s largest investor in biomedical research, the National Institutes of Health.
The politics of the Templeton Foundation's "Big Questions."
Does the profit motive distort and degrade the unpredictable path of scientific discovery?
The US economy rewarded the finance industry at the expense of our most creative problem-solvers. We need an innovation revival to grow our way back to health.
Cell biologist Kenneth Miller discusses the dangers of politicized science.
The United States has fueled a worldwide overreaction to the threat of a bird
flu pandemic, putting AIDS, malaria, malnutrition and other crucial
global health programs at risk.
US drug firms make the choice clear: our outrageous profits or your
life.


